# Cytoskeletal Polymers and Dynamics

> Cells keep their cytoskeleton in constant, regulated turnover so they can explore space, change shape, move and build the division spindle. Actin filaments, microtubules and intermediate filaments are three different polymers, and two of them spend nucleotide energy to stay unstable. This lesson compares their structure and mechanics, derives the critical concentration from the rates at each end, and separates treadmilling from dynamic instability. Afterwards you can read a microtubule length-versus-time trace for growth, shortening, catastrophe and rescue, and predict what a cytoskeletal drug will do, with its dose and test system attached.

Course: Cell Biology (Traffic and movement). Level: core university (third year). About 27 minutes.
Lesson page (link this one when citing): https://stemhop.com/lessons/cytoskeleton-dynamics/

Builds on: Transport Across Membranes · Experiments That Distinguish Mechanisms

## What you'll learn

- Explain why cells use regulated polymer turnover, microtubule dynamic instability and actin treadmilling and network turnover, to explore space, remodel their shape and build the spindle.
- Compare actin filaments, microtubules and intermediate filaments in subunit, width, polarity, nucleotide use and mechanics.
- Derive the critical concentration of an end as koff/kon and explain why hydrolysis lets the two ends of a filament differ, producing treadmilling.
- Read a microtubule length-versus-time trace to obtain growth and shortening velocities and catastrophe and rescue frequencies, and convert a velocity into dimers per second.
- Predict the effects of taxol, nocodazole, colchicine, phalloidin, cytochalasin and latrunculin, stating the dose and the system in which each effect was shown.

**The first film above opens on a microtubule that will not settle down, where a crystal would grow until crystal and solution balance and then stop.**

The instability is not a defect. Ends that grow and collapse by themselves let a microtubule array search the cell interior, keep the ends that find a target, and rebuild quickly when the cell changes shape or divides; regulated actin turnover lets a cell build and take down protrusions. This lesson asks what the three filament systems are made of, what decides whether an end grows or shrinks, and why two of them spend nucleotide energy in a way that keeps them unstable.

## Three polymers built for different jobs

The cytoskeleton is the set of protein filaments in the cytosol, the fluid part of the cytoplasm outside organelles. It has three classes.

|  | Actin filament | Microtubule | Intermediate filament |
| --- | --- | --- | --- |
| Subunit | globular actin | α/β-tubulin heterodimer (a two-protein unit) | fibrous proteins (vimentin in fibroblasts, keratins in epithelial cells) |
| Width | about 7 nm | about 25 nm, a hollow tube of (usually) 13 protofilaments (rows) | about 10 nm |
| Two different ends? | yes: barbed and pointed | yes: plus (β-tubulin exposed) and minus | no |
| Nucleotide | ATP | GTP | none, and no enzyme activity |
| Bending | in between | stiffest | most flexible |

Actin’s barbed and pointed ends are named after the arrowhead pattern seen when fragments of the motor protein myosin decorate a filament in the electron microscope. Actin subunits add head to tail, which is why the filament has two different ends. Tubulin dimers also stack head to tail, into rows called protofilaments, and usually (not always) 13 rows lie side by side to close the tube. Every dimer points the same way, so the tube has a plus end and a minus end. In vimentin and other cytoplasmic intermediate filaments, two rope-like coiled-coil dimers line up antiparallel (in opposite directions) and half staggered (offset) to form a tetramer. A building block that points both ways gives a filament with no polarity. These filaments are not permanent: they exchange subunits slowly, and cells take them apart by phosphorylation, the addition of phosphate tags, as with the nuclear lamins, fibrous proteins of the nuclear scaffold, at mitosis.

In comparisons of purified filaments, microtubules are the stiffest in bending, which suits them to serve as tracks and struts. Intermediate filaments are the most flexible in bending, yet a single filament can be stretched beyond two or three times its resting length without breaking. Think of a rope beside a fishing rod: the rope bends at a touch and is far harder to snap. Flexible is not weak; bending and stretching are different tests.

*Figure (AI-generated illustration).* Three polymers drawn to the same scale. Actin and microtubules have two different ends; the intermediate filament's building block points both ways, so its two ends are alike. Image: three filament segments side by side at the same scale; a thin actin filament with an arrowhead end, a thick hollow microtubule with a plus end, and a rope-like intermediate filament built from antiparallel tetramers.

> **The one idea to carry through this lesson**, the one the first film animates. Each filament end, in a given state, has a critical concentration, Cc = koff / kon. Hydrolysis after assembly gives a polymer a **tight** end (fresh nucleotide, low Cc) and a **loose** end (old nucleotide, high Cc). Between the two Ccs the polymer cannot come to rest with nothing moving. **Actin** separates the two kinds in *space* (treadmilling); **a microtubule end** switches between them over *time* (dynamic instability).

This rule is for single ends with purified proteins. It says *whether* a polymer can settle and *which way* each end moves, not the rates in a cell, where accessory proteins (profilin, formins, cofilin, capping protein, end-binding (EB) proteins and others) change them, some by an order of magnitude or more. It does not say *when* a capped end loses its cap. Intermediate filaments, with no nucleotide and one kind of end, are the contrast case: the rule predicts neither treadmilling nor instability.

## One end: the doorway and its critical concentration

Start with a measurement. Let tubes of pure actin at a range of total concentrations settle, then measure how much is in filaments and how much is free, and plot free actin against total actin.

- **Below a certain total**, nothing polymerizes, so free actin rises in step with total actin.
- **Above that total**, free actin stays flat and every extra subunit goes into polymer, one for one.

The flat level of free actin is the critical concentration, Cc, and it is also the total where the line bends. (For real ATP-actin, whose two ends differ, free actin settles between the two ends’ values; next section.) Followed over time, one tube shows a lag, then growth, then a plateau. The lag is there because starting a filament is hard: a few subunits must come together before an end exists. So cells control *where* filaments start, with formins and the Arp2/3 complex for actin and γ-tubulin at the centrosome for microtubules. Rho-family GTPases decide where actin assembles ([that lesson](https://stemhop.com/lessons/integrins-and-rho-gtpases/)).

Why does free actin stop at one value? Treat a filament end as the film’s doorway: subunits arrive at a rate proportional to the free subunit concentration C, and leave at a rate that does not depend on C.

> **Equation card: Whether one filament end grows or shrinks, and the free subunit concentration at which it does neither.**
>
>     net rate = kon × C − koff; Cc = koff / kon
>
> In words: Net rate equals k on times C, minus k off. Setting it to zero gives the critical concentration, k off divided by k on.
>
> - net rate: subunits gained per second at one end; negative means shrinking (per s)
> - kon: joining rate per micromolar of free subunit (per µM per s)
> - C: the free subunit concentration (µM)
> - koff: how fast subunits leave the end, whatever C is (per s)
> - Cc: the critical concentration, where the end neither grows nor shrinks (µM)
>
> Sanity check: At C = Cc, joining and leaving balance. Above Cc, kon × C beats koff and the end grows; below Cc, loss wins and it shrinks.
> Try one number A growing microtubule plus end in one purified preparation: kon = 8.9 per µM per s and koff = 44 per s. At 10 µM tubulin: 8.9 × 10 − 44 = 89 − 44 = +45 dimers per s, so the end grows. Its critical concentration: 44 / 8.9 ≈ 4.9 µM.

**Predict.** A tube holds total actin at twice the critical concentration. How much is free, and how much is polymer?

> **Check your prediction.** For an end with one Cc: one Cc is free and the other Cc’s worth is polymer. Any free actin above Cc joins filament ends until gain and loss match again.

## Two ends: why hydrolysis makes them differ

So far, one end. A filament has two, and they are built differently: the barbed end adds subunits much faster than the pointed end does (about nine times faster for ATP-actin). Does that give the two ends different critical concentrations?

**Predict.** Imagine actin that never hydrolysed its ATP. Could the barbed end have a lower critical concentration than the pointed end?

> **Check your prediction.** No. Adding one subunit at the barbed end, or one at the pointed end, gives exactly the same result: the same filament, one subunit longer. The energy change is the same, so the balance point, koff/kon, must be the same. The barbed end can be faster at *both* adding and losing, but the ratio cannot differ. Actin holding ADP, which cannot be hydrolysed further, shows this: its two ends have critical concentrations of about 1.9 and 1.7 µM, equal within measurement error.

So a difference between the ends needs a step that spends energy, and that step is hydrolysis. An actin subunit joins carrying ATP, hydrolyses it a little later, then releases the phosphate slowly, so the older lattice holds ADP-actin. ATP-actin binds a filament end more tightly than ADP-actin does, meaning it has a lower critical concentration. Hydrolysis by itself barely loosens a subunit; release of the phosphate does.

In the standard, simplified picture:

- The **barbed end** grows fast, so new ATP-actin keeps arriving before the subunits there have hydrolysed. Its fresh tip makes it a **tight** end, with a low critical concentration.
- The **pointed end** adds subunits slowly, and in the window where treadmilling happens it is losing them, so its tip exposes older subunits that have hydrolysed their ATP and released the phosphate. It is a **loose** end, with a higher critical concentration.

Measured with ATP-actin in solution, the critical concentrations are about 0.1 µM at the barbed end and about 0.6 µM at the pointed end (Pollard, 1986; constants in Going deeper). Put them on a line:

> 0 ─── **0.1 µM** (barbed Cc) ─── **0.6 µM** (pointed Cc) ───→ free ATP-actin

**Predict.** What does each end do with free actin at 0.05 µM, at 0.3 µM and at 1 µM?

> **Check your prediction.** - At 0.05 µM, below both: both ends shrink.
> - At 1 µM, above both: both ends grow, the barbed end about twenty times faster (+10.2 against +0.5 subunits per s).
> - At 0.3 µM, between them: the barbed end grows and the pointed end shrinks.
>
> So “the barbed end grows and the pointed end shrinks” is true only in the window between the two values.

Only the middle zone is new. Left alone, filaments use up free actin until the barbed end’s gain matches the pointed end’s loss. With Pollard’s constants, that happens at about 0.17 µM, close to the barbed end’s value rather than halfway, because the barbed end’s ninefold larger kon gives its value more weight. There the filament keeps its length while subunits flow through it, as the first film shows: **treadmilling**. Single purified actin filaments watched by microscopy show barbed-end growth and pointed-end shortening at approximately equal rates at steady state.

*Figure (AI-generated illustration).* Treadmilling: at steady state the barbed end gains subunits as fast as the pointed end loses them, so the filament keeps its length while subunits flow through it. Image: a ten-bead actin filament with a new bead joining at the barbed end and an older bead leaving the pointed end, a broad arrow showing subunits flowing front to back, and a second strip showing the same length a moment later.

Binding drives assembly; hydrolysis afterwards turns the steady state into a flux. Pure treadmilling is slow, a small fraction of a micrometre per minute, so cells that rebuild actin quickly add proteins that start, speed, cap and sever filaments (see the design problem).

## One end, two states: dynamic instability

A microtubule end switches between steady growth and rapid shortening. The switch to shortening is a **catastrophe**; the switch back is a **rescue**. This **dynamic instability**, a property of individual ends, is the rule’s *time* version: one end alternates between a tight (capped) and a loose (uncapped) state. (Microtubules can treadmill too, in vitro and in some cells, so treadmilling is not limited to actin.)

The standard explanation is the **GTP cap** that the first film animates. The GTP sits on β-tubulin and is hydrolysed soon after the dimer joins, inside the lattice, so the end stays intact only while a cap of not-yet-hydrolysed dimers remains.

- **Capped, the end is tight.** Its critical concentration is about 5 µM in one purified preparation (the worked example in the box above), so at typical test concentrations it grows.
- **Uncapped, the end is loose.** It sheds dimers so fast that its critical concentration is, by a rough estimate, far above any tubulin concentration tested (Going deeper, “Who first watched the switching”).

GDP-tubulin protofilaments are curved, which is why they peel outward once the cap is gone.

Because a cap can be lost by chance even at a steady growth rate, catastrophes are random events. Slowing hydrolysis lengthens the cap, as recombinant human tubulin mutants show (Roostalu and colleagues, 2020). Exactly what the cap looks like, and what final event commits an end to shortening, is still argued.

Mitchison and Kirschner inferred dynamic instability in 1984 from populations of microtubules; microscopy of single ends soon showed the switching directly, at both ends of purified microtubules (Going deeper). In cells, minus ends are often capped or anchored, for example at the centrosome.

**Predict.** A microtubule end has lost its cap and is shortening. Will doubling the free tubulin, say from 7 to 14 µM, slow the shortening?

> **Check your prediction.** Barely. An uncapped end’s critical concentration is out of reach, so a bit more tubulin cannot turn loss into gain. A 1988 study of purified pig brain tubulin saw exactly this: rapid shortening did not change with tubulin concentration over 7 to 15.5 µM. The cap model also fits its second finding, that more tubulin made catastrophes rarer at both ends: a capped end grows faster with more tubulin and is thought to build a bigger cap that is harder to lose, though catastrophe also depends on the age of the end.

### A worked problem: reading one trace

The data below are made up for teaching. They describe one plus end grown from a seed in purified tubulin; length is measured from the seed.

- 0 s, 5.0 µm; steady growth to 180 s, 9.5 µm; catastrophe
- 192 s, 3.5 µm; rescue; steady growth to 312 s, 6.5 µm; catastrophe
- 325 s, 0 µm (back to the seed)

**Step 1, growth velocity.** (9.5 − 5.0) µm over 180 s (3 min) = 1.5 µm per min. The second growth phase gives (6.5 − 3.5) µm over 120 s (2 min) = 1.5 µm per min, the same.

**Step 2, shortening velocity.** 6.0 µm in 12 s = 0.5 µm per s = 30 µm per min, twenty times faster than growth. The second shortening phase, 6.5 µm in 13 s, gives the same 0.5 µm per s.

**Step 3, switching frequencies.** Each frequency is the number of switches divided by the time spent in the state they leave. The end spent 180 + 120 = 300 s growing and had 2 catastrophes: 2/300 = 0.0067 per s, × 60 s = 0.4 per min. It spent 12 + 13 = 25 s shortening and had 1 rescue: 1/25 = 0.04 per s.

**Step 4, dimers per second.** Assume 13 protofilaments and 8 nm per dimer, so one micrometre holds 1,000 nm ÷ 8 nm = 125 dimers per protofilament, and 125 × 13 = 1,625 dimers in all. Growth of 1.5 µm per min is 0.025 µm per s, times 1,625 = about 41 dimers per s.

Check against real data. The box’s example, the 1988 study’s plus-end constants at 10 µM tubulin, gives +45 dimers per s, about 1.7 µm per min by the same conversion. The study’s rapid shortening, 733 dimers per s, is about 27 µm per min. The made-up trace is in the right range.

*Interactive on the lesson page:* One microtubule end — growth, catastrophe, rescue

## Drugs as tests

A drug tests a mechanism only if you know its target, its dose and the system. Each drug below acts on one piece of the rule: free subunits, ends, or the lattice. The second film asks when a perturbation becomes evidence about one of these moving parts.

**Film transcript: When a Drug Becomes a Test**

### Film transcript: When a Drug Becomes a Test

Chapter one linked free subunits, ends, and their lattice. How can a drug turn that rule into a clean test? A drug is informative only when three labels stay attached: its target, dose, and test system. Remove any label, and the same drug name can support the wrong conclusion. Keep the moving parts on screen. Free subunits feed an end; the end adds to or removes from a lattice. A perturbation can act at any of those three places. Latrunculin A binds actin monomers one to one, holding them so they cannot join. The available pool falls, so less actin enters polymer. Yet it can also speed loss at the ends of freshly built filaments. Sequestration is not the whole story.

Cytochalasin B acts elsewhere. Its binding follows filament-end number, not total actin, and it inhibits addition at barbed ends. Phalloidin instead binds along actin filaments. With purified muscle actin, it slows disassembly. Now predict. A drug lowers the amount of polymer. Does that observation alone reveal whether it trapped subunits, blocked ends, or changed the lattice?

No. The same amount change can begin at different sites. Add a second measurement that separates them. Holding total actin constant while changing end number can reveal binding that follows ends. That is the difference between an effect and a mechanism.

Polymer amount reports the outcome. A measurement tied to the proposed target tests how that outcome arose. Target is still not enough; dose changes the experiment. In tested cultured cells, nanomolar nocodazole can pause microtubules and slow growth and shortening. Micromolar doses commonly used on cultured mammalian cells remove most microtubules. The system can change a switching result too. With nocodazole, catastrophe became more frequent in cultured newt lung cells. In BSC-1 monkey kidney cells after an hour, catastrophe became less frequent. Phalloidin shows another system boundary. It slows disassembly with purified muscle actin, but enters living cells poorly.

Fluorescent phalloidin therefore mainly stains filaments after cells are fixed. Sometimes the drug is not selective enough. Withaferin A redistributes vimentin in human fibroblasts, but did not alter purified vimentin assembly. Removing vimentin genetically, then adding it back, is the cleaner test. Read every result as a complete sentence: this target, at this dose, in this system, changed this measurement. Then compare another perturbation aimed at a different step. Chapter one supplied the moving parts behind cytoskeletal turnover. This chapter adds the rule for testing them experimentally. If target, dose, or system changes, the conclusion may change too.

From the film

- A drug tests a mechanism only when its target, dose and test system stay attached.
- The same change in polymer amount can begin at free subunits, filament ends or the lattice.
- Latrunculin A sequesters actin monomers and can also speed loss at the ends of freshly built filaments.
- Nocodazole effects depend on dose and on the cultured cell system.
- A second measurement can separate mechanisms that produce the same outcome.

The table keeps the exact effects and caveats together for reference.

| Drug | Binds | Effect on the polymer | Evidence and caveats |
| --- | --- | --- | --- |
| **Taxol (paclitaxel)** | β-tubulin in the assembled lattice | stabilizes microtubules; drives extra assembly | low doses damp dynamics without adding polymer; higher doses add polymer (worked below) |
| **Colchicine** | free tubulin dimers | the drug-dimer complex adds to an end and blocks further growth there | small amounts suppress dynamics |
| **Nocodazole** | tubulin dimers | depends on dose and cell type | in the cultured cells tested, nanomolar doses pause microtubules and slow growth and shortening; the micromolar doses common on cultured mammalian cells remove most of them |
| **Phalloidin** | along actin filaments | slows disassembly (shown with purified muscle actin) | enters living cells poorly, so fluorescent phalloidin mainly stains filaments in fixed cells |
| **Cytochalasin B** | barbed ends of actin filaments | inhibits addition there | its binding follows the number of filament ends, not the amount of actin |
| **Latrunculin A** | actin monomers, 1:1 | sequesters them (holds them so they cannot join), lowering polymer | can also speed disassembly at filament ends, so sequestration is not the whole story |

The experiments behind most rows are in Going deeper.

**Predict.** Add taxol to growing microtubules at a dose too low to raise the total polymer. Sketch the new length-versus-time trace.

> **Check your prediction.** Slower growth and slower, shorter shortening events, not more polymer: the sawtooth flattens. Taxol binds the assembled lattice, including the old GDP-tubulin behind the cap.

Intermediate filaments have no standard poison. Withaferin A redistributes vimentin in human fibroblasts, but it is not selective and did not alter the assembly of purified vimentin, so removing vimentin genetically and then adding it back is the cleaner test ([experiments that distinguish](https://stemhop.com/lessons/experiments-that-distinguish/)). Neurons use both polar polymers in the [growth cone](https://stemhop.com/lessons/growth-cone/) and for [neuronal polarity](https://stemhop.com/lessons/neuronal-polarity/).

*Figure (AI-generated illustration).* Where each drug binds: taxol inside the assembled lattice, facing the lumen, colchicine and nocodazole on free tubulin dimers, phalloidin along actin filaments, cytochalasin B at their ends, latrunculin A on actin monomers. Effects depend on dose and system. Image: on the left, a cutaway microtubule lattice with a yellow tag inside the wall facing the lumen labelled taxol, and free tubulin dimers beside it with a pink tag labelled colchicine and nocodazole; on the right, a beaded actin filament with a yellow tag along its side labelled phalloidin, a pink tag at one end labelled cytochalasin B, and loose actin monomers, one with a pink tag labelled latrunculin A.

### Design problem

In a cultured fibroblast, the total actin fluorescence in the lamellipodium, the thin sheet at the leading edge, looks constant over 5 minutes. Design an experiment to decide whether the filaments there are static or treadmilling. First ask: why can’t the total intensity decide?

> **One way to do it.** A treadmilling network and a static one can hold the same polymer. Mark part of it and follow the mark (see [microscopy and images](https://stemhop.com/lessons/microscopy-and-images/) and fluorescence recovery after photobleaching, or FRAP, in [membrane organization](https://stemhop.com/lessons/membrane-organization-topology/)).
>
> 1. Express fluorescent actin and either bleach a narrow stripe across the lamellipodium, photoactivate a small patch of photoactivatable actin, or label sparsely so the network shows random speckles.
> 2. Image every few seconds while the edge holds still. Treadmilling: the mark moves rearward and fades at the back while fresh fluorescence appears at the front. Static filaments: the mark stays put and does not recover. Exchange all along the filaments: the mark recovers in place without moving.
> 3. Predict that, with the edge stationary, the mark’s rearward speed equals the speed at which new network is added at the front.
>
> Controls: a fixed cell, where the mark should neither move nor recover; an unbleached region, to measure bleaching by imaging alone; and jasplakinolide, which stabilizes actin filaments and should slow the mark. With the edge still, a rearward-moving mark shows that the network flows back while new network is added in front; assembly pushing and myosin pulling both drive that flow. Fading of the mark, after correcting for bleaching, shows polymer being lost as it moves back. A lamellipodium is a branched network of short filaments rather than single long filaments, and in cells its fast turnover depends on accessory proteins such as ADF/cofilin, profilin and capping protein. Neither observation says which proteins drive either step.

## Going deeper

### Checking the rule against measured constants

Pollard (1986) measured elongation at each end of purified actin at 22 °C, using Limulus acrosomal seeds. Elongation at each end rose linearly with ATP-actin concentration up to 20 micromolar, and the slopes and intercepts gave separate rate constants for each end. For ATP-actin: barbed kon 11.6 per µM per s, koff 1.4 per s (Cc 0.12 µM); pointed 1.3 and 0.8 (Cc 0.62 µM). For ADP-actin: barbed 3.8 and 7.2 (Cc 1.9 µM); pointed 0.16 and 0.27 (Cc 1.7 µM). The ADP-actin pair checks the one-Cc argument. The steady-state concentration, (1.4 + 0.8)/(11.6 + 1.3) ≈ 0.17 µM, is an average of the two critical concentrations weighted by each end’s kon. The flux there is about 0.6 subunits per second, under a tenth of a micrometre per minute, likely an upper estimate, since real pointed ends carry older, ADP-containing subunits. (These constants are as tabulated in Pollard and Borisy, 2003.)

### Who first watched the switching, and in what preparation

Mitchison and Kirschner proposed dynamic instability in 1984 from measurements on populations of microtubules in vitro: the way numbers and lengths changed over time fitted growing and shrinking microtubules that coexist and interconvert rather infrequently. Single microtubules were watched switching in real time soon after, by dark-field microscopy (Horio and Hotani, 1986) and by video [light microscopy](https://stemhop.com/methods/light-microscopy/) in Ted Salmon’s laboratory (Walker and colleagues, 1988). The Walker study used pig brain tubulin free of associated proteins, grown from axoneme fragments at 37 °C, and found both ends dynamic; rapid shortening at the plus end ran at 733 dimers per second.

If an uncapped end accepted dimers no faster than a capped one (kon no more than 8.9 per µM per s), its Cc would be at least 733 / 8.9 ≈ 82 µM plus the tubulin concentration itself, a rough bound far above the 7 to 15.5 µM tested.

### How fast does the cap mature

In the 2020 mutant-tubulin study that lengthened the cap (Roostalu and colleagues), the binding of end-binding (EB) proteins, which recognize the cap region, suggested that the cap matures gradually, with a wild-type rate estimated near 0.2 per second. This is an estimate in one recombinant system.

### Drug effects that depend on the system

**Taxol.** With purified microtubule protein, Schiff and Horwitz found in 1981 that taxol-treated microtubules resisted disassembly on dilution and that taxol drove extra assembly after an apparent steady state. In HeLa cells, taxol did not raise microtubule polymer mass below 10 nM but did at higher doses, and submicromolar taxol suppressed both growing and shortening of purified brain microtubules (Jordan and colleagues, 1993).

**Cytochalasin B.** Brown and Spudich showed in 1981 that its binding follows the number of filament ends, by changing the number of ends on actin-coated beads while holding total actin constant. That experiment shows end binding; it does not by itself show which end. That the bound end is the barbed end came from other experiments.

**Nocodazole and latrunculin A.** In cultured newt lung epithelial cells, 4 to 400 nM nocodazole introduced a paused state, slowed both growth and shortening and made catastrophes more frequent (Vasquez and colleagues, 1997); in BSC-1 monkey kidney cells after an hour the effects were similar, except that catastrophes became less frequent. So the direction of one switching parameter depends on the system. Latrunculin A binds actin monomers with an apparent Kd of about 0.2 µM in pure actin. Single-filament imaging in 2018 found it binds ATP-actin far more tightly than ADP-actin (0.1 versus 4.7 µM) and also speeds disassembly at the ends of freshly assembled ATP-actin filaments and slowly severs them.

---

From STEMhop (https://stemhop.com), free lessons by Christopher Deppmann. Lesson text © the authors. Practice questions: https://stemhop.com/lessons/cytoskeleton-dynamics/
